His most important contributions include pre-clinical and clinical studies that introduced inhibition of angiotensin receptor (59, 60) and angiotensin-converting enzyme (ACE) (61–65) as effective therapies for the treatment of patients with hypertension or heart failure. The gene discussed is ACE; the disease is hypertensive disorder.